CYR61 downregulation correlates with tumor progression by promoting MMP-7 expression in human gastric carcinoma

Oncology

Volumn 73, Issue 1-2, 2008, Pages 118-126

  Maeta, Noritaka ^a   Osaki, Mitsuhiko ^a,b   Shomori, Kohei ^a   Inaba, Aiko ^a   Kidani, Kazunori ^a   Ikeguchi, Masahide ^a   Ito, Hisao ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

CYR61; Gastric carcinoma; MMP 7; Serotonin

Indexed keywords

CYSTEINE RICH PROTEIN 61; MATRILYSIN; TUMOR MARKER;

ADENOMA; ARTICLE; CANCER INVASION; CARCINOGENESIS; CARCINOMA CELL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; LYMPH NODE METASTASIS; LYMPHATIC SYSTEM; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEOMICS; STOMACH CARCINOMA; STOMACH MUCOSA; TISSUE DIFFERENTIATION; TUMOR GROWTH; WESTERN BLOTTING;

ADENOMA; BLOTTING, WESTERN; CARCINOMA; DISEASE PROGRESSION; FLUORESCENT ANTIBODY TECHNIQUE; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHATIC METASTASIS; MATRIX METALLOPROTEINASE 7; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 41549164034     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000121000     Document Type: Article

References (39)

1. O'Brien TP, Yang GP, Sanders L, Lau LF: Expression of cyr61, a growth factor-inducible immediate-early gene. Mol Cell Biol 1990;10:3569-3577.
2. Perbal B: NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol Pathol 2001;54:57-79.
3. Brigstock DR: The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev 1999;20:189-206.
4. Pennica D, Swanson TA, Welsh JW, Roy MA, Lawrence DA, Lee J, Brush J, Taneyhill LA, Deuel B, Lew M, Watanabe C, Cohen RL, Melhem MF, Finley GG, Quirke P, Goddard AD, Hillan KJ, Gurney AL, Botstein D, Levine AJ: WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci USA 1998;95:14717-14722.
5. Planque N, Perbal B: A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis. Cancer Cell Int 2003;3:15.
6. 3 binding site in CCN1 (CYR61) critical for pro-angiogenic activities in vascular endothelial cells. J Biol Chem 2004;279:44166-44176.
7. 1 transition of cultured mouse cells. EMBO J 1985;4:3145-3151.
8. 3 and cell surface heparin sulfate proteoglycans. Endocrinology 2002;143:1441-1450.
9. Babic AM, Kireeva ML, Kolesnikova TV, Lau LF: CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA 1998;95:6355-6360.
10. Tsai MS, Bogart DF, Castaneda JM, Li P, Lupu R: CYR61 promotes breast tumorigenesis and cancer progression. Oncogene 2002;21:8178-8185.
11. Xie D, Yin D, Tong X, O'Kelly J, Mori A, Miller C, Black K, Gui D, Said JW, Koeffler HP: CYR61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and β-catenin-TCF/Lef signaling pathways. Cancer Res 2004;64:1987-1996.
12. Menendez JA, Mehmi I, Griggs DW, Lupu R: The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives. Endocr Relat Cancer 2003;10:141-152.
13. Tsai MS, Bogart DF, Li P, Mehmi I, Lupu R: Expression and regulation of CYR61 in human breast cancer cell lines. Oncogene 2002;21:964-973.
14. Holloway SE, Beck AW, Girard L, Jaber MR, Barnett CC Jr, Brekken RA, Fleming JB: Increased expression of CYR61 (CCN1) identified in peritoneal metastasis from human pancreatic cancer. J Am Coll Surg 2005;200:371-377.
15. Pilarsky CP, Schmidt U, Eissrich C, Stade J, Froschermaier SE, Haase M, Faller G, Kirchner TW, Wirth MP: Expression of the extracellular matrix signaling molecule CYR61 is downregulated in prostate cancer. Prostate 1998;36:85-91.
16. Sampath D, Zhu Y, Winneker RC, Zhang Z: Aberrant expression of CYR61, a member of the CCN (CTGF/CYR61/Cef10/NOVH) family, and dysregulation by 17 β-estradiol and basic fibroblast growth factor in human uterine leiomyomas. J Clin Endocrinol Metab 2001;86:1707-1715.
17. Croci S, Landuzzi L, Astolfi A, Nicoletti G, Rosolen A, Sartori F, Follo MY, Oliver N, De Giovanni C, Nanni P, Lollini PL: Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells. Cancer Res 2004;64:1730-1736.
18. Tong X, Xie D, O'Kelly J, Miller CW, Muller-Tidow C, Koeffler HP: CYR61, a member of CCN family, is a tumor suppressor in nonsmall cell lung cancer. J Biol Chem 2001;276:47709-47714.
19. Nishigaki R, Osaki M, Hiratuka M, Toda T, Murakami K, Jeang KT, Ito H, Inoue T, Oshimura M: Proteomic identification of differentially-expressed genes in human gastric carcinomas. Proteomics 2005;5:3205-3213.
20. Mori M, Mimori K, Yoshikawa Y, Shibuta K, Utsunomiya T, Sadanaga N, Tanaka F, Matsuyama A, Inoue H, Sugimachi K: Analysis of the gene-expression profile regarding the progression of human gastric carcinoma. Surgery 2002;131:S39-S47.
21. Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma - 2nd English edition. Gastric Cancer 1998;1:10-24.
22. Hayashi H, Tatebe S, Osaki M, Goto A, Sato K, Ito H: Anti-Fas antibody-induced apoptosis in human colorectal carcinoma cell lines: role of the p53 gene. Apoptosis 1998;3:431-437.
23. Kitoh T, Yanai H, Saitoh Y, Nakamura Y, Matsubara Y, Kitoh H, Yoshida T, Okita K: Increased expression of matrix metalloproteinase-7 in invasive early gastric cancer. J Gastroenterol 2004;39:434-440.
24. Ito H, Yokozaki H, Tokumo K, Nakajo S, Tahara E: Serotonin-containing EC cells in normal human gastric mucosa and in gastritis. Virchows Arch 1986;409:313-323.
25. Ito H, Hata J, Oda N, Miyamori S, Tahara E: Serotonin in tubular adenomas, adenocarcinomas and endocrine tumours of the stomach. Virchows Arch 1986;410:239-245.
26. Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Miwa S, Tsuneyama K, Takano Y: Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray. J Clin Pathol 2007;60:273-277.
27. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM: Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 2000;18:1135-1149.
28. Crawford HC, Matrisian LM: Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis 1995;14:234-245.
29. Egeblad M, Werb Z: New functions for the matrix metalloproteinase in cancer progression. Nat Rev Cancer 2002;2:161-174.
30. Imai K, Yokohama Y, Nakanishi I, Ohuchi E, Fujii Y, Nakai N, Okada Y: Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. J Biol Chem 1995;270:6671-6677.
31. Parsons SL, Watson SA, Brown PD, Collins HM, Steele RJ: Matrix metalloproteinase. Br J Surg 1997;84:160-166.
32. Yamashita K, Azumano I, Mai M, Okada Y: Expression and tissue location of matrix metalloproteinase 7 (matrilysin) in human gastric carcinoma: implications for vessel invasion and metastasis. Int J Cancer 1998;79:187-194.
33. Chambers AF, Matrisian LM: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997;89:1260-1270.
34. Yamamoto H, Horiuchi S, Adachi Y, Taniguchi H, Nosho K, Min Y, Imai K: Expression of ets-related transcriptional factor E1AF is associated with tumor progression and overexpression of matrilysin in human gastric cancer. Carcinogenesis 2004;25:325-332.
35. Brigstock DR: The CCN family: a new stimulus package. J Endocrinol 2003;178:169-175.
36. Manendez JA, Mehmi I, Griggs DW, Lupu R: The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives. Endocr Relat Cancer 2003;10:141-152.
37. Mitra A, Chakrabarti J, Chatterjee A: Binding of alpha5 monoclonal antibody to cell surface alpha5beta1 integrin modulates MMP-2 and MMP-7 activity in B16F10 melanoma cells. J Environ Pathol Toxicol Oncol 2003;22:167-178.
38. Soon LL, Yie TT, Shvarts A, Levine AJ, Su F, Tchou-Wong KM: Overexpression of WISP-1 down-regulated motility and invasion of lung cancer cells through inhibition of Rac activation. J Biol Chem 2003;278:11465-11470.
39. Lin MT, Zuon CY, Chang CC, Chen ST, Chen CP, Lin BR, Wang MY, Jeng YM, Chang KJ, Lee PH, Chen WJ, Kuo ML: CYR61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/ cyclooxygenase-2 signaling pathway. Clin Cancer Res 2005;11:5809-5820.